2009
DOI: 10.1007/s12098-009-0254-3
|View full text |Cite
|
Sign up to set email alerts
|

Vincristine induced neurotoxicity in cancer patients

Abstract: Ten out of 20 children, treated with usual doses of vincristine for various types of childhood cancers, developed neurotoxicity during treatment. Peripheral neurotoxicity (mixed motor-sensory 4/10, pure motor 3/10, pure sensory 3/10) was seen in the form of weakness of lower limbs, areflexia, neuropathic pain, or sensory loss. Autonomic neuropathy presented as constipation and urinary retention in 2 children, while 2 children developed encephalopathy in form of seizures, confusion, aphasia, and transient blind… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
68
0
4

Year Published

2010
2010
2019
2019

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 88 publications
(73 citation statements)
references
References 11 publications
(8 reference statements)
1
68
0
4
Order By: Relevance
“…Methotrexate was not used in any protocols for the present sample. Although the chemotherapy agents used to treat pediatric brain tumors have not been associated with significant neurocognitive late effects, peripheral neuropathy resulting in motor slowing can be observed following treatment with vincristine (Gomber et al, 2010;Ramchandren et al, 2009), and auditory toxicity that may interfere with measurement of auditory-verbal functions can be associated with cisplatin (McHaney et al, 1983;Weatherly et al, 1991). There is a possibility that the chemotherapeutic agents used to treat pediatric brain tumors have an impact on cognitive function and thus requires continued examination.…”
Section: Discussionmentioning
confidence: 99%
“…Methotrexate was not used in any protocols for the present sample. Although the chemotherapy agents used to treat pediatric brain tumors have not been associated with significant neurocognitive late effects, peripheral neuropathy resulting in motor slowing can be observed following treatment with vincristine (Gomber et al, 2010;Ramchandren et al, 2009), and auditory toxicity that may interfere with measurement of auditory-verbal functions can be associated with cisplatin (McHaney et al, 1983;Weatherly et al, 1991). There is a possibility that the chemotherapeutic agents used to treat pediatric brain tumors have an impact on cognitive function and thus requires continued examination.…”
Section: Discussionmentioning
confidence: 99%
“…Some are being investigated as potential neuroprotectors, as seen below. Malnourished and alcoholic patients and those with previous gastrointestinal surgery are at special risk of developing neuropathy [62,63], since some of these essential vitamins have had their absorption compromised.…”
Section: Prevention: Neuroprotectionmentioning
confidence: 99%
“…relatively higher incidence of vincristine-induced neuropathy in Indian children and authors attributed it to coexistence of severe malnutrition in those patients. 16 According to one research finding, vincristine causes peripheral neuropathy and the patients who suffers peripheral neuropathy experiences problems related to cardiovascular, gastrointestinal and genitourinary systems. 16 In addition, patients who experienced peripheral neuropathy, a side-effect from chemotherapy could be disabled after using antineoplastic agents.…”
Section: Discussionmentioning
confidence: 99%
“…16 According to one research finding, vincristine causes peripheral neuropathy and the patients who suffers peripheral neuropathy experiences problems related to cardiovascular, gastrointestinal and genitourinary systems. 16 In addition, patients who experienced peripheral neuropathy, a side-effect from chemotherapy could be disabled after using antineoplastic agents. 17 One study noticed, in children the lower age could resulted in greater sensitivity of some nerves to vincristine and thus showing a motor predominant neuropathy in children.…”
Section: Discussionmentioning
confidence: 99%